Ceapro Announces Termination of Investor Relations Contract
(firmenpresse) - EDMONTON, ALBERTA, CANADA -- (Marketwire) -- 10/02/12 -- Ceapro Inc. (TSX VENTURE: CZO) wishes to inform its shareholders that it has terminated its month to month contract with Renmark Financial Communications Inc. to provide investor relations services.
Questions regarding press releases can be forwarded to Branko Jankovic, the Chief Financial Officer.
About Ceapro Inc.
Ceapro Inc. is a Canadian growth-stage biotechnology company. Primary business activities relate to the development and commercialization of active ingredients for personal care and cosmetic industries using proprietary technology and natural, renewable resources. The commercial line of natural active ingredients include beta glucan, avenanthamides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides.
To learn more about Ceapro, visit .
The TSX Venture Exchange nor its Regulation Services Provide (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contacts:
Branko Jankovic
Chief Financial Officer
Ceapro Inc.
780.917.8376 (Edmonton)
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 03.10.2012 - 00:00 Uhr
Sprache: Deutsch
News-ID 189060
Anzahl Zeichen: 0
contact information:
Town:
EDMONTON, ALBERTA, CANADA
Kategorie:
Biotech
Diese Pressemitteilung wurde bisher 309 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Ceapro Announces Termination of Investor Relations Contract"
steht unter der journalistisch-redaktionellen Verantwortung von
Ceapro Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
